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Abstract	22	
Objectives	To	determine	 the	population	structure	of	E.	coli	 ST73	 isolated	 from	23	 human	bacteraemia	and	urinary	tract	infections	24	
Methods	 The	 genomes	 of	 22	 E.	 coli	 ST73	 isolates	 were	 sequenced	 using	 the	25	 Illumina	 HiSeq	 platform.	 High	 resolution	 SNP	 typing	 was	 used	 to	 create	 a	26	 phylogenetic	 tree.	 Comparative	 genomics	 were	 also	 performed	 using	 a	27	 pangenome	 approach.	 In	 silico	 and	 S1-PFGE	 plasmid	 profiling	 was	 conducted,	28	 and	isolates	were	checked	for	their	ability	to	survive	exposure	to	human	serum	29	
Results	E.	coli	 ST73	 isolates	 circulating	 in	 clinically	unrelated	episodes	 show	a	30	 high	degree	of	diversity	at	a	whole	genome	level,	though	exhibit	conservation	in	31	 gene	content,	particularly	in	virulence	associated	gene	carriage.	The	isolates	also	32	 contain	 a	 highly	 diverse	 plasmid	 pool	 that	 confers	 multi-drug	 resistance	 via	33	 carriage	 of	 CTX-M	 genes.	 All	 strains	 are	 highly	 serum	 resistant	 and	 uniformly	34	 carry	genes	shown	to	be	essential	for	serum	resistance.	35	
Conclusions	Our	data	 shows	 that	 a	 rise	 in	 incidence	of	multi-drug	 resistant	E.	36	
coli	ST73	clinical	 isolates	 is	not	due	to	a	circulating	outbreak	strain	as	 in	E.	coli	37	 ST131.	 Rather	 the	 ST73	 circulating	 strains	 are	 distantly	 related	 and	 carry	 a	38	 diverse	 set	 of	 resistance	 plasmids.	 This	 suggests	 that	 the	 evolutionary	 events	39	 behind	emergence	of	drug	resistant	E.	coli	differ	between	lineages.	40	
	 	41	
Introduction	42	 Extra-intestinal	pathogenic	Escherichia	coli	(ExPEC)	is	the	term	used	to	describe	43	 strains	 of	 E.	 coli	 which	 can	 asymptomatically	 colonise	 the	 intestinal	 tract	 of	44	 humans	and	animals,	but	cause	disease	in	non-intestinal	sites.1	In	humans	ExPEC	45	 most	commonly	cause	urinary	tract	infections,	which	is	thought	to	affect	as	many	46	 as	 70%	 of	 the	 global	 female	 population.1	 ExPEC	 are	 also	 capable	 of	 causing	47	 bacteraemia	infections,	where	large	numbers	of	bacterial	cells	gain	entry	to	the	48	 bloodstream	 causing	 a	 potentially	 life-threatening	 infection.	 The	 incidence	 of	49	 bacteraemia	caused	by	ExPEC	has	been	 increasing	rapidly	 in	 the	past	10	years,	50	 with	ExPEC	now	the	most	common	cause	of	bacteraemia	 in	Europe,	overtaking	51	 MRSA	and	Clostridium	difficile	bloodstream	infections.2		52	 The	rise	in	cases	of	ExPEC	bacteraemia	is	mirrored	by	a	marked	increase	in	the	53	 carriage	of	multi-drug	resistance	(MDR)	plasmids	in	ExPEC.	In	particular	ExPEC	54	 are	associated	with	the	sustained	carriage	and	dissemination	of	genes	encoding	55	 ESBL,	 and	 especially	 the	CTX-M	variant.	 In	 some	 countries	 as	many	 as	 50%	of	56	 bacteraemia	 ExPEC	 isolates	 are	 ESBL	 positive	 isolates.2	 Numerous	57	 epidemiological	 studies	 have	 shown	 the	 E.	 coli	 ST131	 clone	 to	 be	 the	 most	58	 commonly	isolated	MDR	ExPEC	strain	type	from	human	clinical	cases.3,4	ST73	is	59	 another	phylogroup	B2	strain	 type	 that	 is	also	 frequently	 isolated	 from	human	60	 clinical	 cases.4	 Unlike	 ST131,	 which	 has	 been	 extensively	 studied	 and	61	 characterised	 at	 a	 population	 and	 genomic	 level,5–7	 very	 little	 is	 known	 about	62	 ST73	beyond	the	reference	ExPEC	strain	CFT073.	8		63	 We	 recently	 conducted	 a	 molecular	 epidemiological	 survey	 of	 bacteraemia	64	 ExPEC	 isolates	 from	the	East	Midlands	area	of	 the	United	Kingdom.9	Our	study	65	 found	 that	 MDR	 ExPEC	 were	 significantly	 more	 abundant	 in	 bacteraemia	66	
samples	 than	 clinical	 urine	 samples	 over	 a	 concomitant	 time	 frame.	 Perhaps	67	 more	 surprisingly	 our	 study	 also	 showed	 that	 ST73	 prevalence	 had	 risen	 to	68	 become	the	most	commonly	 isolated	MDR	ExPEC	strain	 type	 from	bacteraemia	69	 samples,	 and	 not	 ST131	 as	 observed	 in	 a	 previous	 study	 in	 the	 same	 region.4		70	 Given	that	the	rapid	increase	in	clinical	cases	of	MDR	E.	coli	ST131	is	attributable	71	 to	rapid	global	dissemination	of	a	successful	clone	,6,7	we	sought	to	determine	if	72	 the	high	incidence	of	MDR	ST73	clinical	isolates	from	our	bacteraemia	study	was	73	 also	due	to	the	emergence	of	a	successful	dominant	clone.		74	
	75	
Methods	76	
Bacterial	isolates.	An	epidemiological	investigation	of	bacteraemia	and	urinary	77	 tract	infection	(UTI)	E.	coli	isolates	conducted	by	our	group	in	2013	identified	an	78	 increase	in	the	number	of	E.	coli	ST73	clinical	isolates	containing	the	CTX-M	gene	79	 conferring	 multi-drug	 resistance.9	 Twenty-two	 isolates	 were	 selected	 for	80	 sequencing	incorporating	10	ESBL	positive	blood	isolates,	2	ESBL	negative	blood	81	 isolates,	3	ESBL	positive	UTI	isolates,	and	7	ESBL	negative	UTI	isolates	(table	1).		82	 These	were	selected	to	represent	the	diversity	in	ESBL	phenotype	in	the	samples	83	 population.		84	
Genome	 sequencing	 and	 analysis.	 Isolates	 were	 sequenced	 on	 the	 Illumina	85	 HiSeq2500	 platform	 using	 2	 x	 250bp	 PE	 sequencing	 (Table	 1).	 Genome	86	 assemblies	were	performed	using	Velvet	and	PAGIT,10	which	reordered	contigs	87	 based	 on	 the	 CFT073	 reference	 genome.8	 Assembled	 genomes	were	 annotated	88	 using	 Prokka.11	 Progressive	 Mauve	 was	 used	 to	 create	 a	 whole	 genome	89	 alignment	 of	 the	 assembled	 genomes.12	 High-resolution	 SNP	 typing	 was	90	 performed	 by	mapping	 fastQ	 files	 against	 the	 reference	 ST73	 genome	 CFT073	91	
using	 SMALT	 (https://www.sanger.ac.uk/resources/software/smalt/#t_2)	 and	92	 Samtools.	Resulting	VCF	 files	were	 filtered	using	vcftools13	 to	 retain	only	 SNPs	93	 with	a	MinQ	30,	MinDP	10,	 and	MinAF	0.8.	The	 filtered	VCF	 files	were	used	 to	94	 produce	a	consensus	sequence	for	each	strain	relative	to	CFT073.	The	sequences	95	 were	 aligned	using	Mugsy14	 from	which	 a	maximum	 likelihood	phylogeny	was	96	 created	using	RaxML	 implementing	 the	GTR-Gamma	model.15	All	 raw	sequence	97	 data	 has	 been	 deposited	 in	 the	 European	 Nucleotide	 Archive	 under	 project	98	 accession	number	PRJEB9931.	99	
Pangenome	 analysis.	A	 pangenome	 of	 the	 22	 sequenced	 strains	 and	 CFT073	100	 was	 made	 using	 Gegenees.16	 To	 determine	 if	 there	 were	 loci	 associated	 with	101	 bacteraemia	in	ST73,	the	genetic	content	of	bacteraemia	isolates	was	compared	102	 against	UTI	 isolates	using	a	 cut-off	of	80%	 identity	across	80%	of	bacteraemia	103	 strains,	 and	80%	 identity	 across	 20%	of	UTI	 strains.	An	 identical	 analysis	was	104	 conducted	 for	 ESBL	 positive	 against	 ESBL	 negative	 to	 attempt	 to	 identify	 loci	105	 associated	 with	 ESBL	 carriage.	 Presence	 of	 virulence-associated	 genes17	 was	106	 determined	by	BlastN	analysis	of	gene	sequences	against	the	de	novo	assembled	107	 genome	of	each	strain.		108	
Plasmid	typing.	In	silico	plasmid	typing	was	performed	using	a	locally	installed	109	 version	of	the	PlasmidFinder	database.18	Assembled	genomes	were	compared	to	110	 the	 database	 using	 BlastN	 to	 identify	 plasmid	 types	 present	 in	 each	 genome.	111	 Plasmid	profiling	was	also	performed	using	the	S1-PFGE	method.19		112	
	113	
Results	114	
The	observed	increase	in	MDR	E.	coli	ST73	clinical	isolates	is	due	to	a	highly	115	
diverse	group	of	strains.	116	
Sequence	 data	 for	 all	 22	 isolates	 was	 mapped	 against	 the	 CFT073	 reference	117	 genome	 and	 a	 high-resolution	 SNP	 phylogenetic	 tree	 was	 constructed	 (Fig	 1).		118	 The	phylogenetic	 tree	 shows	 that	 bacteraemia	 and	UTI	 isolates	 are	 intermixed	119	 throughout	 the	phylogeny,	 as	are	ESBL	positive	and	negative	 isolates.	Pairwise	120	 SNP	 distance	 calculations	 between	 isolates	 showed	 that	 the	 minimum	 SNP	121	 distance	 between	 any	 two	 isolates	 was	 416	 SNPs,	 and	 the	maximum	 distance	122	 6,026	SNPs	(Fig	S1.A).		123	
Comparative	genomic	analysis	 indicates	diversity	between	ST73	genomes	124	
occurs	at	single	base	pair	mutation	level,	and	in	plasmid	repertoire.	125	 An	alignment	of	all	the	ST73	genomes	using	progressiveMauve	indicated	genetic	126	 variation	predominantly	occurring	 in	small	contigs	of	 the	assemblies	(Fig	S2.A)	127	 suggestive	that	most	gene-content	variation	occurs	in	plasmids	and	other	mobile	128	 genetic	 elements	 (MGE).	We	 created	 a	 pangenome	 of	 the	 ST73	 genomes	 using	129	 Gegenees	 (Fig	 S2.B)	 showing	 a	 core	 genome	 of	 3.81Mbp,	 and	 1201	 conserved	130	 CDS	from	a	total	of	10,696	CDS,	consistent	with	analyses	performed	on	the	E.	coli	131	 species	and	on	E.	coli	ST131.20,21	We	performed	in	silico	analysis	to	determine	the	132	 presence	 of	 the	 major	 ExPEC	 virulence-associated	 genes	 in	 our	 data	 set	 (Fig	133	 S2.C).	This	shows	some	differences	in	carriage	of	virulence	genes	but	a	relatively	134	 fixed	virulence	gene	profile.	The	comparison	of	UTI	and	bacteraemia	isolates	for	135	 virulence	gene	carriage	also	showed	identical	profiles	between	the	two	groups.	136	 We	 sought	 to	 identify	 the	 presence	 of	 any	 loci	 over-represented	 in	 the	UTI	 or	137	 bacteraemia	group	of	strains,	or	in	the	ESBL	positive	and	ESBL	negative	group	of	138	 strains	using	Gegenees.	This	analysis	failed	to	identify	any	loci	associated	with	a	139	 propensity	towards	bacteraemia	or	ESBL	carriage.		140	
Highly	 diverse	 plasmid	 repertoire	 in	 circulating	 clinical	 E.	 coli	 ST73	141	
isolates.		142	 Given	 the	observations	of	our	pangenome	analysis	we	sought	 to	determine	 the	143	 extent	 of	MGE	 diversity	 in	 our	 ST73	 isolates,	 focussing	 primarily	 on	 plasmids.	144	 Using	the	PlasmidFinder	database	we	performed	 in	silico	plasmid	typing	on	our	145	 22	 isolates	 (Table	1).	Our	 analysis	 showed	 that	 FII,	 FIA	 and	FIB	plasmid	 types	146	 were	 predominant.	 To	 further	 investigate	 this	we	 performed	 S1-PFGE	plasmid	147	 profiling	 of	 every	 isolate.	 No	 plasmids	 were	 detected	 in	 the	 CTX-M	 negative	148	 isolates,	but	a	large	number	of	plasmid	molecules	were	detected	in	the	remaining	149	 isolates	(Table	1).	A	112Kbp	plasmid	was	found	in	6	isolates	which	showed	the	150	 most	similar	accessory	gene	content	in	the	pangenome	analysis.	Superimposing	151	 of	 the	 plasmid	 typing	 data	 on	 the	 phylogenetic	 tree	 showed	 that	 the	 112Kbp	152	 plasmid	 is	 present	 in	 the	 6	 isolates	 that	 showed	 the	 lowest	 amount	 of	 core	153	 genome	 diversity	 (Fig	 1).	 We	 compared	 the	 similarity	 of	 genomes	 at	 gene	154	 content	 level	 using	 the	 fragmented	 all-against-all	 comparison	 in	 Gegenees	 to	155	 show	 that	 the	 6	 strains	 sharing	 the	 112kb	 plasmid	 also	 showed	 gene	 content	156	 similarity	 above	 95%	 (Fig	 S1.B)	 suggesting	 that	 the	 plasmid	 pool	 in	 these	 6	157	 strains	is	highly	similar	if	not	identical.		158	
Discussion	159	 Epidemiological	studies	in	the	East	Midlands	area	of	the	UK	have	highlighted	an	160	 increase	in	incidence	of	E.	coli	ST73	MDR	isolates	over	the	past	5	years.4,9	In	this	161	 study	we	present	the	genomic	analysis	of	22	ST73	isolates	from	human	clinical	162	 bloodstream	and	UTI	cases,	all	 isolated	within	a	3-month	period	from	the	same	163	 region	 of	 the	 United	 Kingdom.	 Our	 analysis	 shows	 levels	 of	 diversity	 in	 the	164	 hundreds	 or	 thousands	 of	 SNPs	 between	 isolates.	 This	 is	 in	 stark	 contrast	 to	165	
ST131,	 where	 isolates	 from	 the	 identical	 UK	 region	 over	 a	 6	 month	 period	166	 showed	 diversity	 of	 under	 10	 SNPs	 between	 strains	 isolated	 from	 unrelated	167	 clinical	episodes,	and	a	maximum	diversity	of	dozens	of	SNPs.5		168	 Analysis	 of	 our	 ST73	 genomic	 data	 set	 identified	 the	 presence	 of	 a	 limited	169	 number	 of	 plasmid	 types	 based	 on	 in	silico	 rep	 typing,	 however	 both	 genomic	170	 analysis	and	classical	plasmid	profiling	show	plasmid	diversity	in	the	small	ST73	171	 population	sampled	here.	The	presence	of	a	112Kbp	plasmid	was	 inferred	 in	6	172	 isolates,	which	were	also	the	6	most	closely	related	isolates	phylogenetically	and	173	 at	gene	content	level.	It	is	tempting	to	speculate	there	may	be	a	circulating	sub-174	 clone	of	 ST73	but	 such	 inference	 is	hampered	by	our	 small	 and	geographically	175	 restricted	sample	size.		176	 The	small	population	we	have	sequenced	limits	the	inferences	we	can	make	from	177	 our	data	set.	However	there	are	several	key	points	that	our	study	highlights.	The	178	 first	is	that	the	evolution	and	emergence	of	MDR	lineages	of	ExPEC	does	not	have	179	 a	 one-size-fits-all	 model.	 E.	 coli	 ST131	 became	 a	 predominant	 clinical	 ExPEC	180	 isolate	by	 clonal	 expansion	and	 rapid	 global	dissemination	of	 an	MDR	clone	of	181	 the	wider	ST131	lineage.7	Our	data	of	clinically	unrelated	ST73	isolates	shows	a	182	 highly	diverse	population	of	circulating	ST73	strains,	with	a	diverse	plasmid	pool	183	 driving	 multi-drug	 resistance	 in	 this	 lineage.	 In	 order	 to	 gain	 a	 more	184	 comprehensive	understanding	of	the	emergence	and	population	structure	of	this	185	 important	 lineage	 of	 pathogenic	E.	coli	 it	 is	 vitally	 important	 that	 larger	 global	186	 isolate	 collections	 are	 analysed.	 Equally	 as	 important	 is	 that	 these	 collections	187	 include	non-human	reservoir	isolates.	By	doing	this	we	will	acquire	a	far	greater	188	 understanding	 of	 the	 ways	 in	 which	 ExPEC	 lineages	 can	 emerge	 as	 dominant	189	 MDR	clinical	isolates,	and	move	our	focus	beyond	just	E.	coli	ST131.		190	
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Table	1.	List	of	isolates	and	genome	assembly	statistics	used	in	this	study	261	
Isolate	 PCR	ESBL	
type	
Genome	
size	(bps)	
N	
Contigs	
N50	
contig	
size	
%	
mapped	
reads	
S1-PFGE	
plasmid	
profile	
In	silico	Inc	typing	
B10	 CTX-M-15	 5173276		
	
106	 108731	 94.5	 112Kbp	 FIB(AP001918),	FII,	Col156	
	
B14	 Negative	 5099552		
	
158	 113745	 90.21	 Negative	 	
B18	 CTX-M-15	 5120683		
	
125	 122417	 91.93	 33.5Kbp,	
48.5Kbp	
Non-typable	
B29	 CTX-M-15	 5261474	 168	 101820	 93.7	 112Kbp	 FIB(AP001918),	FII	Col156	
B36	 CTX-M-15	 5191523	 152	 125321	 92.26	 145Kbp	 FIB(pB171),	FII,	Col156	
B40	 CTX-M-15	 5257611	 165	 103459	 91.43	 140Kbp	 FIA,	FIB(AP001918)	
B72	 CTX-M-15	 5158804	 110	 134654	 84.53	 33.5Kbp,	
82	Kbp	
FII(pRSB107)	
B73	 CTX-M-15	 5150717	 156	 121329	 94.38	 112Kbp	 FIB(AP001918),	FII,	Col156	
B84	 CTX-M-15	 5182704	 137	 134972	 93.42	 112Kbp	 FIB(AP001918),	FII,	Col156	
B91	 CTX-M-15	 5155911	 197	 79515	 90.23	 120Kbp	 FIB(S),	FII,	Col156	
B102	 Negative	 5075956	 160	 87164	 93.51	 Negative	 	
B134	 OXA-1	
CTX-M-15	
5230535	 154	 116039	 93.61	 82Kbp	 FIB(AP001918),	FII,	FIA	
U1	 Negative	 5243352	 151	 123112	 86.52	 Negative	 	
U7	 Negative	 5176031	 145	 126228	 93.16	 Negative	 	
U21	 Negative	 5145668	 162	 113459	 91.81	 Negative	 	
U24	 Negative	 5120446	 147	 110560	 89.83	 Negative	 	
U30	 Negative	 5287542	 160	 139416	 87.12	 Negative	 	
U36	 Negative	 5162072	 138	 114804	 91.04	 Negative	 	
U42	 CTX-M-15	 5188710	 155	 106920	 93.92	 112Kbp	 FIB(AP001918),	 Col156,	 Col8282,	
Col(MG828)	
U48	 Negative	 5080928	 112	 113440	 87.44	 Negative	 	
U50	 CTX-M-15	 5256879	 145	 117621	 94.03	 48.5Kbp	 FII	
U76	 CTX-M-15	 5179037	 140	 133761	 94.11	 112Kbp	 FIB(AP001918),	FII,	Col156	
Isolates	with	the	prefix	B	were	isolated	from	bacteraemia	cases,	those	with	prefix	U	from	UTI.	%	reads	262	
mapped	equates	to	reads	mapped	against	the	CFT073	genome	263	
N50	 is	 a	weighted	median	 statistic	 such	 that	 50%	of	 the	entire	 assembly	 is	 contained	 in	 contigs	 or	264	
scaffolds	equal	to	or	larger	than	this	value	265	
	266	
	267	
	 	268	
Figure	 1.	Maximum	 likelihood	 phylogenetic	 tree	 of	 clinical	 ST73	 isolates,	 with	 S1-269	
PFGE	 and	 in	 silico	 plasmid	profiling	 superimposed.	 Plasmid	 sizes	 as	 determined	by	270	
S1-PFGE,	and	inc-types	as	determined	by	in	silico	analysis	are	indicated	in	the	legend	271	
to	 the	 right.	This	 figure	appears	 in	colour	 in	 the	online	version	of	 JAC	 and	 in	black	272	
and	white	in	the	printed	version	of	JAC	273	
	274	
Figure	 S1.	 (A)	Pairwise	distance	matrix	of	 the	number	of	 SNPs	difference	between	275	
any	 two	 isolates	 on	 the	 phylogenetic	 tree.	 Numbers	 of	 SNPs	 are	 relative	 to	 those	276	
obtained	 from	mapping	against	 the	CFT073	 reference	genome	 for	each	 isolate.	 (B)	277	
Pairwise	comparison	of	percentage	similarity	between	each	genome	at	gene	content	278	
level,	 as	 determined	 by	 fragmented-all-against-all	 comparison	 in	 Gegenees.	 This	279	
figure	appears	 in	 colour	 in	 the	online	version	of	 JAC	 and	 in	black	and	white	 in	 the	280	
printed	version	of	JAC	281	
	282	
Figure	 S2.	 Comparative	 genomics	 of	 ST73	 isolates.	 (A)	Mauve	 alignment	 of	 all	 22	283	
isolates	alongside	CFT073.	Co-coloured	blocks	indicate	genome	segments	containing	284	
syntenic	genetic	 loci.	Regions	 to	 the	3’	end	of	 the	alignment	 indicate	 low	 levels	of	285	
synteny.	(B)	Pangenome	analysis	of	the	22	ST73	isolates	alongside	CFT073.	Levels	of	286	
nucleotide	 identity	 between	 genomic	 regions	 are	 indicated	 as	 heatmap	 colours.	287	
Green	 regions	 indicate	 genomic	 segments	 with	 levels	 of	 identity	 above	 80%	 at	288	
nucleotide	level,	down	to	red	regions	that	indicate	levels	of	identity	below	20%.	(C)	289	
Heatmap	representation	of	carriage	of	common	ExPEC	virulence	associated	genes	in	290	
bacteraemia	 and	 UTI	 isolates	 of	 ST73.	 This	 figure	 appears	 in	 colour	 in	 the	 online	291	
version	of	JAC	and	in	black	and	white	in	the	printed	version	of	JAC	292	
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